Clarus Therapeutics' Series C Round

Clarus Therapeutics raised a round of funding on November 21, 2007.

Clarus is an emerging men's specialty pharmaceutical company preparing for the commercial launch of REXTORO, an oral testosterone, or T, replacement therapy. On January 3, 2014 the Company submitted a…

Articles about Clarus Therapeutics' Series C Round: